Open original FDA record ↗Recall record
- FDA identifier
- Z-0205-06
- Company in FDA record
- Namsa
- FDA classification date
- Nov 29, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The certified Ethylene Oxide D-values of the lots cannot be confirmed to be within specification.
Source facts
- Action
- The firm contacted consignees by phone on or about 3/18/05 and sent a follow up letter on or about 3/31/05. Consignees are asked to contact their customers if they further distributed the product.
- Initiated
- 2005-03-18
- Root cause
- Other
- Terminated
- 2012-04-12
- Distribution
- Domestic accounts: SRI International, 333 Ravenswood, Menlo Park, CA 94025; NAMSA, 6750 Wales, Northwood, OH 43619; Smiths Medical ASD, Inc., 10 Bauman Drive, Keene, NH 03431; Medisystems, 701 Pike St., Seattle, WA 98101; Inverness, 17-10 Willow St., Fairlawn, NJ 07410; International Accounts: Sterisure Associates, Shop No-2 Parachawl, Jijama, Pump House Mumbai India; Biomedical Research and Support Services (BRASS), 59 Ubi Ave., #06-04 Bizlink Center, Singapore 65 67426007
- Recall number
- Z-0205-06
- Recall status
- Terminated
- CDRH record ID
- 38155
- FDA classified
- 2005-11-29
- Recall event number
- 31560